에 대한 최신 뉴스 HCA Healthcare (NYSE:HCA) 주식

HCA Healthcare

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of June 2024, the firm owned and operated 188 hospitals, 123 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.

Government

News

Regulations

Health Care

Politics

Legal

Movers

General

NOVA

화요일 오후, 워싱턴 D.C.의 한 연방 판사가 도널드 트럼프 대통령이 모든 연방 보조금과 대출을 동결한 행정 명령을 일시적으로 차단했다. 이 명령은 3조 달러의 자금을 위험에 빠뜨리고 전체 산업을 불안하게 만들었다.

美 연방 판사가 트럼프의 연방 보조금 및 대출 동결 명령을 일시적으로 저지

Equities

Large Cap

Sector ETFs

Econ #s

Markets

ETFs

PowerShares Exchange Traded Fund Trust WilderHill Clean Energy Portfolio

SEDG

백악관이 모든 연방 보조금과 대출에 대한 일시적인 동결을 명령하면서 3조 달러의 자금이 재검토를 받게 되었고, 이는 의회의 재정 권력에 대한 법적 및 정치적 충돌의 무대를 설정하여 광범위한 산업에 큰 영향을 미칠 수 있다. 이 지침은 월요일에 예산관리국(OMB)에 의해 발행되었고 여러 언론 매체에 의해 수신되었다. 모든 연방 기관은 프로그램이 도널드 트럼프 대통령의 정책 우선사항과 일치하는지 검토되는 동안 지급을 중단해야 한다.

트럼프의 연방 지출 중단으로 $3조가 위기에 봉착, 클린 에너지, 방산, 의료 등 산업이 위협

Earnings

Pre-Market Outlook

Trading Ideas

CNN 머니 공포·탐욕 지수는 목요일(23일)에 &#39;중립&#39; 영역으로 이동하면서 전반적인 시장 심리가 더 개선된 것으로 나타났다. 목요일 미국 증시는 도널드 트럼프 대통령이 유가 인하를 촉구한 후 S&amp;P 500 지수가 장중 사상 최고치를 기록하는 등 상승세로 마감했다.

트럼프 발언 이후 S&amp;P 500 사상 최고치 기록, 공포·탐욕 지수는 &#39;중립&#39; 영역으로 이동

HCA Healthcare Inc

HOLDING CO ADMIE IPTO by Holding Co Admie Ipto SA

Holding Co ADMIE (IPTO) SA

Huachen AI Parking Management Technology Holding Co., Ltd. - Ordinary Shares

Huachen AI Parking Management Technology Holding Co Ltd

HALO COLLECTIVE INC by HALO COLLECTIVE INC.

Halo Collective Inc

Health Catalyst Inc

HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) has outperformed the market over the past 10 years by 5.72% on an annualized basis producing an average annual return of 17.15%. Currently, HCA Healthcare has a market capitalization of $84.87 billion. 
Buying $100 In HCA: If an investor had bought $100 of HCA stock 10 years ago, it would be worth $486.25 today based on a price of $335.07 for HCA at the time of writing.
<h3>HCA Healthcare's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738337414_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

A federal judge in the District of Columbia on Tuesday afternoon temporarily blocked an executive order given by President Donald Trump that imposed a freeze of all federal grants and loans, putting $3 trillion in funding in jeopardy and <a href="https://www.benzinga.com/25/01/43290381/trumps-federal-spending-freeze-puts-3-trillion-in-limbo-threatens-industries-like-clean-energy-defense-healthcare">entire industries on edge.&nbsp;</a>
The Details: According to a New York Times <a href="https://www.nytimes.com/2025/01/28/us/politics/trump-funding-freeze-blocked.html">report</a>, Judge Loren AliKhan blocked the order late Tuesday afternoon in response to a lawsuit filed by Democracy Forward. The lawsuit argued the directive violated the First Amendment and the Administrative Procedures Act governing the issuance of executive orders. 
Judge AliKhan said she will issue a more permanent decision on Feb. 3 
Read Next: <a href="https://www.benzinga.com/news/large-cap/25/01/43106379/trump-reverses-bidens-ai-policies-on-day-1-what-it-means-for-tech-giants-nvidia-amd-alphabet">Trump Reverses Biden&#8217;s AI Policies On Day 1: What It Means For Tech Giants Nvidia, AMD, Alphabet&nbsp;</a>
Skye Perryman, Democracy Forward's president and chief executive, commented on the judge's decision in a statement.&nbsp;
"We are grateful for this administrative stay to allow our clients time to sort through the chaos created by the Trump administration's hasty and ill-advised actions," Perryman said, per the New York Times. 
Trump's directive, issued Monday by the Office of Management and Budget, required federal agencies to halt disbursements while programs were reviewed for alignment with Trump administration policies and was slated to go into effect on Tuesday at 5 p.m. ET.&nbsp;
But, early Tuesday, state Medicaid programs reported the federal reimbursement portals had been locked. State officials said funding for community health centers, food for families, housing assistance, preschools and disaster relief was in limbo.
According to the New York Times, the White House and OMB said on Tuesday afternoon the funding freeze did "not apply across-the-board" and affected programs on D.E.I. efforts and funding for organizations "that undermine the national interest."
Stocks To Watch: It remains unclear exactly which industries could be affected by Trump's order or if the judge will elect to block it permanently on Feb 3.&nbsp;
However, Medicaid funding had reportedly been stopped at least temporarily. HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) and Universal Health Services Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) stocks fell on Tuesday. 
Large defense contractors like RTX Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) and Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) also face a growing degree of uncertainty regarding government funding and contracts.
Green industries including solar energy could also be on the chopping block for federal funding due to Trump administration policies. Sunnova Energy International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) dropped 12% Tuesday and Sunrun, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) fell 9.2% amid the uncertainty on future policy changes. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/01/43287988/microsoft-q2-preview">Microsoft Q2 Earnings Preview: Street &#8216;Too Optimistic&#8217; On Near-Term AI Returns?&nbsp;</a></li>
</ul>
Photo: Shutterstock

Judge Blocks Trump's Order To Freeze Federal Grant Money

The White House has ordered a temporary freeze on all federal grants and loans, putting $3 trillion in funding under scrutiny and setting the stage for a legal and political showdown over the congressional power of the purse that could heavily impact a <a href="https://www.benzinga.com/markets">wide range of industries.</a>
The directive, issued Monday by the Office of Management and Budget and received by several media outlets, requires all federal agencies to halt disbursements while programs are reviewed for alignment with President Donald Trump's policy priorities.
This includes halting new awards, existing payment and funding for projects until reviewed.
The exact financial impact of the order remains uncertain. Budget experts cited <a href="https://www.washingtonpost.com/business/2025/01/28/trump-spending-freeze-upends-washington-triggering-legal-threats-delays/">by the Washington Post </a>estimate at least tens of billions of dollars are at stake, though the White House directive suggests the total could be significantly higher.
Of the almost $10 trillion spent by the federal government in fiscal 2024, more than $3 trillion was federal financial assistance, Matthew Vaeth, acting director at the OMB, said in the memorandum.
&#8220;Financial assistance should be dedicated to advancing Administration priorities,&#8221; Vaeth said, adding that &#8220;the use of Federal resources to advance Marxist equity, transgenderism, and green new deal social engineering policies is a waste of taxpayer dollars that does not improve the day-to-day lives of those we serve.&#8221;
The White House said that Social Security and Medicare remain untouched. The sweeping pause threatens funding for universities, nonprofits, contractors and private companies that depend on federal assistance.
&#8220;Nothing in this memo should be construed to impact Medicare or Social Security benefits,&#8221; the memo said. 
The immediate focus will be on how agencies handle exemptions. The OMB memo allows federal departments to request case-by-case approvals, which means some funding may still flow, but the process is likely to be slow and politically charged.
Federal agencies have until Feb. 10, 2025, to provide OMB with detailed reports outlining which programs, projects, and activities are affected by the funding pause.
<h3 class="wp-block-heading">Legal, Political Showdown Over Federal Funds </h3>
The move is triggering legal challenges from nonprofits and Democratic-led states.
Within hours of the announcement, lawsuits were filed in federal courts in New York, Illinois and Oregon, arguing that Trump does not have the authority to withhold congressionally approved spending.
Senate Minority Leader Chuck Schumer was among the first to push back, saying Congress-approved investments are legally mandated and asserting the president lacks the authority to override the Impoundment Control Act of 1974, which restricts unilateral executive control over federal funds.
Trump has long argued that the 1974 law is unconstitutional, stating that past presidents had far more discretion over spending before its passage.
<h3 class="wp-block-heading">Which Industries Could Face Trouble?</h3>
Some of the hardest-hit sectors could include clean energy, defense, health care and education, where federal dollars have played a crucial role in driving investment and growth in recent years.
Trump's OMB memo explicitly targeted climate initiatives and green energy programs. Shares of solar and renewable energy companies were among the hardest hit following the federal funding freeze.
The Invesco Solar ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAN#NYSE">TAN</a>) and the Invesco Wilderhill Clean Energy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBW#NYSE">PBW</a>) fell by 2% and 1.3%, respectively, on Tuesday. 
Sunnova Energy International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) dropped 12%, Sunrun Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) fell 9.2% and SolarEdge Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) declined 5%. 
Defense contractors such as Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), RTX Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) and Northrop Grumman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) may also see rising uncertainty. While military spending is unlikely to be cut outright, several defense contractors rely on federal grants for research and development. 
The impact on health care remains unclear. While Medicare is shielded, Medicaid funding — which supports hospitals, managed care providers and pharmaceutical companies — could be at risk.
HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) and Universal Health Services Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) fell by 1% and 1.4%, respectively, while Tenet Healthcare Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) showed resilience Tuesday. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43281252/fed-set-to-signal-no-rush-to-cut-rates-as-wall-street-awaits-policy-clarity">Fed Set To Signal No Rush To Cut Rates As Wall Street Awaits Policy Clarity</a></li>
</ul>
Photo via Shutterstock.

Trump's Federal Spending Freeze Puts $3 Trillion In Limbo, Threatens Industries Like Clean Energy, Defense, Health Care

RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) with a Outperform and lowers the price target from $405 to $384.

Price Target

Analyst Ratings

RBC Capital Maintains Outperform on HCA Healthcare, Lowers Price Target to $384

B of A Securities analyst Kevin Fischbeck maintains HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) with a Buy and lowers the price target from $380 to $370.

B of A Securities Maintains Buy on HCA Healthcare, Lowers Price Target to $370

HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) reported better-than-expected earnings for its <a href="https://www.benzinga.com/quote/HCA/earnings">fourth quarter on Friday</a>.
The company posted fourth-quarter revenues of $18.29 billion, up 5.7% year-over-year, slightly above the consensus of $18.23 billion. The hospital chain reported adjusted EPS of $6.22, up from $5.90 a year ago, surpassing the consensus of $6.13. 
&#8220;We finished 2024 with strong business fundamentals that were consistent with previous quarters,&#8221; said Sam Hazen, Chief Executive Officer of HCA Healthcare. &#8220;The first half of the current decade, which ended in 2024, proved to be another period of long-term growth for the company and resulted in operational improvements across key performance indicators and greater value for our patients, employees and shareholders. These accomplishments are a testament to the incredible work of our teams, and position us well for the future.&#8221;
HCA Healthcare forecasts 2025 EPS of $24.05-$25.85 versus a consensus of $24.58, with a sales outlook of $72.8 billion-$75.8 billion versus a consensus of $74.76 billion.
The company expects a 2025 net profit of $5.85 billion-$6.29 billion and adjusted EBITDA of $14.30 billion—$15.10 billion. Capital expenditures for 2025, excluding acquisitions, are estimated to be approximately $5.0 billion to $5.2 billion.
HCA Healthcare shares fell 3.8% to close at $313.07 on Friday.
These analysts made changes to their price targets on HCA Healthcare following earnings announcement.
<ul>
<li>Barclays analyst Andrew Mok maintained HCA Healthcare with an Overweight rating and lowered the price target from $392 to $366.</li>
<li>Cantor Fitzgerald analyst Sarah James reiterated HCA Healthcare with an Overweight rating and maintained a $405 price target.</li>
</ul>
Considering buying HCA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="560" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/27090101/image-207-1024x560.png" alt="" class="wp-image-751323" style="width:575px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/27090101/image-207-1024x560.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/27090101/image-207-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/27090101/image-207-768x420.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/27090101/image-207.png 1162w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/markets/25/01/43189390/top-3-materials-stocks-that-may-fall-off-a-cliff-in-january">Top 3 Materials Stocks That May Fall Off A Cliff In January</a></li>
</ul>

These Analysts Revise Their Forecasts On HCA Healthcare Following Q4 Results

Cantor Fitzgerald analyst Sarah James reiterates HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) with a Overweight and maintains $405 price target.

Reiteration

Cantor Fitzgerald Reiterates Overweight on HCA Healthcare, Maintains $405 Price Target

Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) with a Overweight and lowers the price target from $392 to $366.

Barclays Maintains Overweight on HCA Healthcare, Lowers Price Target to $366

Wall Street paused for a breather on Friday, with the S&amp;P 500 index hovering around the flatline at midday trading in New York after a five-day rally that pushed the market to fresh record highs this week. Meanwhile, investor attention shifted to <a href="https://www.benzinga.com/markets/forex">forex and gold markets.</a>
The greenback is experiencing its worst weekly performance since July 2023, as President Donald Trump refrained from imposing new tariffs during his first week and escalated pressure on the Federal Reserve, urging the central bank to lower interest rates. The U.S. dollar index – tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>) – dropped 0.7% on Friday, extending its weekly decline to 1.7%.
Adding to the dollar's downward momentum, the Bank of Japan raised interest rates by 25 basis points to 0.5%, the highest level since 2008, in a move that broadly met expectations.
Gold capitalized on the dollar's weakness and rising tensions between the president and the central bank, marking another week of strong gains and approaching all-time highs. The bullion, tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), was trading at $2,777 per ounce.
On the macro front, S&amp;P Global reported a slowdown in private sector growth in January, as the services sector faced an unexpected setback, despite manufacturing expanding for the first<a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43195427/us-services-growth-slows-manufacturing-finally-expands-in-january-inflation-was-broad-based-expert-warns"> time in seven months.</a>
A warning came from the University of Michigan's consumer survey, which downwardly revised the January consumer confidence indicator and pointed to increasing trends of households making purchases in advance to avoid potential price hikes <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43197024/consumer-confidence-declines-as-buying-in-advance-trends-grow">linked to tariffs.</a>
In the cryptocurrency market, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) climbed 2.5% following Trump's executive order signed on Thursday, aimed at strengthening U.S. leadership in digital assets. 
<h3 class="wp-block-heading">Friday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,314.96</td>
<td>0.0%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,119.65</td>
<td>0.0%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,541.76</td>
<td>-0.1 %</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,861.02</td>
<td>-0.2%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 1:00 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012425&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) eased 0.1% to $608.89.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;inched 0.1% lower to $444.96.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) slipped 0.4% to $530.73.</li>
<li>The&nbsp;iShares Russell 2000 ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) stalled at $229.40.</li>
<li>The&nbsp;Utilities Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) outperformed, up 0.9%; the&nbsp;Technology Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 0.4%.</li>
</ul>
<h3 class="wp-block-heading">Friday&#8217;s Stock Movers</h3>
<ul>
<li>American Express Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) fell 2.4% after reporting fourth-quarter results. </li>
<li>Other stocks moving on quarterly results were Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>), up 1.3%, NextEra Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>), up 4%, HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>), down 3.2%, First Citizens BancShares Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>), up 3.1%, Ericsson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERIC#NASDAQ">ERIC</a>), down 14.3%, Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), down 3.6%, Texas Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>), down 7.1%, and CSX Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NASDAQ">CSX</a>), down 2.8%. </li>
<li>Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) soared 8.1% after new weight loss drug amycretin showed strong trial results. </li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43198272/us-stocks-hit-dot-com-era-valuations-vs-bonds-why-some-experts-remain-bullish">US Stocks Hit Dot-Com Era Valuations Vs. Bonds: Why Some Experts Remain Bullish</a></li>
</ul>
Photo: Shutterstock

Macro Economic Events

Mid Cap

Broad U.S. Equity ETFs

Specialty ETFs

Commodities

Forex

Economics

$BTC

SPDR Dow Jones Industrial Average ETF Trust

ERIC

FCNCA

ISRG

PowerShares DB US Dollar Index Bullish Fund

Stocks Stall, Gold Nears Record Highs As Dollar Faces Worst Week Since July 2023: What's Driving Markets Friday?

WIIM

HCA Healthcare shares are trading lower after the company issued 2025 EPS guidance of $24.05-$25.85 versus a consensus of $24.58, and sales guidance of $72.80B-$75.80B versus a consensus of $74.76B.

HCA Healthcare Exec Says Patient Volumes In Q4 Were Impacted By Both The Hurricane And A Depressed Respiratory Season

On Friday,&nbsp;HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>)&nbsp;reported fourth-quarter revenues of $18.29 billion, up 5.7% year-over-year, slightly above the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $18.23 billion</a>.
The hospital chain reported adjusted EPS of $6.22, up from $5.90 a year ago, surpassing the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43188066/hca-healthcare-reports-fourth-quarter-2024-results-and-provides-2025-guidance" rel="noreferrer noopener">consensus of $6.13</a>.
In the fourth quarter of 2024, same-facility admissions increased 3% year over year, while same-facility equivalent admissions increased 3.1%.
Same-facility emergency room visits increased by 2.4%, same-facility inpatient surgeries increased by 2.8%, and same-facility outpatient surgeries declined by 1.3%.
Same facility revenue per equivalent admission increased by 2.9%. For the fourth quarter of 2024, adjusted EBITDA totaled $3.71 billion, compared to $3.62 billion a year ago.
During the fourth quarter of 2024, the company incurred additional expenses and experienced loss of revenues estimated at $200 million, or $0.60 per diluted share, associated with Hurricane Helene&#8217;s impact on its North Carolina facilities, as well as from Hurricane Milton, which impacted certain facilities in Florida.
HCA Healthcare&#8217;s board has authorized an additional share repurchase program for up to $10 billion.
HCA declared a quarterly cash dividend of&nbsp;$0.72&nbsp;per share on its common stock, up from the $0.66 dividend&nbsp;paid in December. The dividend will be paid on March 31 to stockholders of record at the close of business on March 17, 2025.
Guidance:&nbsp;HCA Healthcare forecasts 2025 EPS of $24.05-$25.85 versus a consensus of $24.58, with a sales outlook of $72.8 billion-$75.8 billion versus a consensus of $74.76 billion.
The company expects a 2025 net profit of $5.85 billion-$6.29 billion and adjusted EBITDA of $14.30 billion—$15.10 billion.
Capital expenditures for 2025, excluding acquisitions, are estimated to be approximately <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">$5.0 billion to $5.2 billion.</a>
Price Action:&nbsp;HCA Healthcare stock is down 0.463% at $323.86&nbsp;at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/01/43187095/novo-nordisks-weekly-amycretin-delivers-up-to-22-weight-loss-in-study-stock-soars" target="_blank" rel="noreferrer noopener">Novo Nordisk&#8217;s Weekly Amycretin Delivers Up to 22% Weight Loss in Study, Stock Soars</a></li>
</ul>
Photo: raker/Shutterstock.com.

Guidance

Dividends

Buybacks

HCA Healthcare Q4 Earnings Beat Steet Estimates Despite Hurricane Impact, Announces $10 Billion Share Buyback Program

2025 Guidance
Today, the Company issued the following estimated guidance for 2025:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">2025 Guidance Range</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenues</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$72.80 to $75.80 billion</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net Income Attributable to HCA Healthcare, Inc.</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$5.85 to $6.29 billion</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$14.30 to $15.10 billion</td>
</tr>
<tr>
<td colspan="1" rowspan="1">EPS (diluted)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$24.05 to $25.85 per diluted share</td>
</tr>
</tbody>
</table>
</figure>
Capital expenditures for 2025, excluding acquisitions, are estimated to be approximately $5.0 to $5.2 billion.

HCA Healthcare Expects 2025 EPS Of $24.05-$25.85 Versus Consensus Of $24.58, With Sales Guidance Of $72.80B-$75.80B Versus Consensus Of $74.76B

HCA Healthcare's Board Of Directors Has Authorized An Additional Share Repurchase Program For Up To $10B

HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) reported quarterly earnings of $6.22 per share which beat the analyst consensus estimate of $6.13 by 1.47 percent. This is a 5.42 percent increase over earnings of $5.90 per share from the same period last year. The company reported quarterly sales of $18.29 billion which beat the analyst consensus estimate of $18.23 billion by 0.30 percent. This is a 5.68 percent increase over sales of $17.30 billion the same period last year.

HCA Healthcare Q4 2024 Adj EPS $6.22 Beats $6.13 Estimate, Sales $18.29B Beat $18.23B Estimate

U.S. stock futures fell on Friday following a 25 basis point rate hike by the Bank of Japan. Futures of all four indices declined.
BOJ hiked the interest rates to 0.5% from 0.25%, the highest in 17 years since the 2008 financial crisis.
The market closed higher on Thursday extending their winning streak as S&amp;P 500 closed at a fresh record close.
The 10-year Treasury note yielded 4.62%, while the two-year note yielded 4.27%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a> indicated a strong 99.5% probability that the Federal Reserve will hold interest rates steady at its upcoming meeting on Jan. 31, 2025. 
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.14%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.10%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.10%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.09%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) both experienced negative premarket trading on Friday. SPY declined by 0.09% to $609.22, and QQQ fell 0.09% to $532.14, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From The Last Session
U.S. stocks closed higher on Thursday, with the S&amp;P 500 reaching record highs after President Donald Trump called for lower oil prices. Speaking at the World Economic Forum via videoconference, Trump advocated for increased oil and gas production, a 15% corporate tax rate for businesses relocating to the U.S., and tariffs on countries with large trade deficits, warning Europe, Canada, and China.
U.S. initial jobless claims rose by 6,000 to 223,000 for the week ending Jan. 18, slightly above estimates. All S&amp;P 500 sectors closed higher, with healthcare, real estate, and industrials posting notable gains.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>1.28%</td>
<td>20,053.68 </td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.53%</td>
<td>6,118.71</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.92%</td>
<td>44,565.07</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.47%</td>
<td>2,314.60</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
The chief technical strategist at LPL Financial, Adam Turnquist said that there are plenty of catalysts underpinning the recent advance. According to him, Trump brings a pro-growth agenda to Washington, with expectations of reduced regulations and lower taxes.
Market breadth has not kept pace with the recent stock rebound, said Turnquist, suggesting the advance has been relatively narrow. Although price and breadth disparities can last for a while, they often signal potential weaknesses in a rally that could stall.
&#8220;While we are not making a call for an imminent correction, investors should not be surprised if one develops this year as history shows they occur at least once per year,&#8221; he added.
Despite these overhangs, Ryan Detrick, the chief market strategist at Carson Research said in an X post that &#8220;this is a bull market and stocks are the place to be overweight in your portfolio&#8221;.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">They tried to scare you with &#39;weak market breadth&#39; or higher interest rates or a hawkish Fed or Washington drama or Year of the snake, etc. Bottom line, as we&#39;ve been saying since November 2022, this is a bull market and stocks are the place to be overweight in your portfolio. <a href="https://t.co/iAs9jMMklV">pic.twitter.com/iAs9jMMklV</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1882536474064925141?ref_src=twsrc%5Etfw">January 23, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Detrick also highlighted the data since 1950, stating that the post-election years could do better if it is a President&#8217;s second term.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Going back to 1950, post election years do better if it is a President&#39;s second term. <a href="https://t.co/7rGQSj44DH">pic.twitter.com/7rGQSj44DH</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1882473698898374715?ref_src=twsrc%5Etfw">January 23, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures</a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on today:
<ul>
<li>On Friday, S&amp;P flash services PMI and manufacturing PMI will be released at 9:45 a.m. ET.</li>
</ul>
<ul>
<li>Existing home sales for December and consumer sentiment data for January will be released at 10 a.m., ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>American Express Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) was up 0.32% in the premarket on Friday ahead of its earnings before the opening bell. Analysts expect it to report quarterly earnings of $3.04 per share on revenue of $17.16 billion.</li>
</ul>
<ul>
<li>Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) was up 0.48% as Wall Street expects it to report quarterly earnings of $1.10 per share on revenue of $35.32 billion before the opening bell.</li>
</ul>
<ul>
<li>HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) was up 2.03% ahead of its earnings before the opening bell. Analysts expect it to report quarterly earnings of $6.13 per share on revenue of $18.23 billion.</li>
</ul>
<ul>
<li>Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) was down 2.25% as it issued conservative guidance despite reporting better-than-expected earnings and sales results for the fourth quarter after the market closed on Thursday.</li>
</ul>
<ul>
<li>Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) was down 1.83% as it warned investors of steeper quarterly losses and lower revenue in its preliminary fourth-quarter financial results. It also expects a $3.5 billion cash flow loss due to labor strikes and layoffs.</li>
</ul>
<ul>
<li>Allurion Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) was up 92.97% as it announced plans to conduct a clinical study of its gastric balloon weight-loss product alongside GLP-1 drugs.</li>
</ul>
<ul>
<li>Starbox Group Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STBX#NASDAQ">STBX</a>) was up 74.48% as it entered a software purchase agreement valued at $15.5 million via share issuance.</li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 0.31% to hover around $74.85 per barrel.
The gold spot index was up by 0.50% to $2,778.90 per ounce. The Dollar Index was down 0.66% at 107.336 level.
Asian markets closed mixed on Friday as India's S&amp;P BSE Sensex and Japan's Nikkei 225 index fell. Whereas, China's CSI 300, Hong Kong's Hang Seng, Australia's ASX 200, and South Korea's Kospi index rose. European markets were also mixed.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/01/43184963/nvidia-microsoft-or-oracle-which-among-these-stargate-ai-project-beneficiaries-are-the-least-expensive-to-own">Nvidia, Microsoft, Or Oracle: Which Stock Among These Stargate AI Project Beneficiaries Are The Least Expensive To Own?</a></li>
</ul>
Photo courtesy: Shutterstock

Analyst Color

Market Summary

Futures

ALUR

STBX

US Stocks Set To Open Lower After Bank Of Japan Rate Hike: Analyst Recommends 'Overweight' Equities Despite Negative Market Breadth

<h3>Companies Reporting Before The Bell</h3>
• Bright Scholar Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEDU#NYSE">BEDU</a>) is expected to report earnings for its first quarter. 
• Moog Inc. Class A Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOG#NYSE">MOG</a>) is expected to report quarterly earnings at $1.70 per share on revenue of $873.04 million. 
• Verizon Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) is projected to report quarterly earnings at $1.10 per share on revenue of $33.73 billion. 
• South Plains Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPFI#NASDAQ">SPFI</a>) is projected to report quarterly earnings at $0.68 per share on revenue of $49.16 million. 
• First Citizens BancShares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>) is estimated to report quarterly earnings at $39.14 per share on revenue of $2.21 billion. 
• Lakeland Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKFN#NASDAQ">LKFN</a>) is estimated to report quarterly earnings at $0.90 per share on revenue of $63.09 million. 
• Northwest Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWBI#NASDAQ">NWBI</a>) is expected to report quarterly earnings at $0.25 per share on revenue of $141.53 million. 
• NextEra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>) is projected to report quarterly earnings at $0.53 per share on revenue of $7.98 billion. 
• HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) is likely to report quarterly earnings at $6.16 per share on revenue of $18.23 billion. 
• Telefonaktiebolaget L M (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERIC#NASDAQ">ERIC</a>) is expected to report quarterly earnings at $0.18 per share on revenue of $7.01 billion. 
• American Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) is expected to report quarterly earnings at $2.98 per share on revenue of $17.14 billion. 
<h3>Companies Reporting After The Bell</h3>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BEDU

LKFN

NWBI

SPFI

Earnings Scheduled For January 24, 2025

The CNN Money Fear and Greed index showed further improvement in overall market sentiment, while the index moved to the &#8220;Neutral&#8221; zone on Thursday.
U.S. stocks settled higher on Thursday, with the S&amp;P 500 surging to record highs during the session after President Donald Trump called for cheaper oil prices.
Trump addressed the World Economic Forum via videoconference, advocating for expanded oil &amp; gas production and proposing a 15% corporate tax rate for businesses relocating manufacturing to the U.S. He also reiterated plans to impose tariffs on countries with large trade deficits with the U.S., issuing warnings to Europe, Canada, and China.
American Airlines Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) reported better-than-expected fourth-quarter 2024 results but issued a weak outlook. GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) reported stronger-than-expected earnings for its fourth quarter.
On the economic data front, U.S. initial jobless claims increased by 6,000 from the previous week to 223,000 in the week ending Jan. 18, compared to market estimates of 220,000.
All sectors on the S&amp;P 500 closed on a positive note, with health care, real estate, and industrials stocks recording gains on Thursday.
The Dow Jones closed higher by around 408 points to 44,565.07 on Thursday. The S&amp;P 500 rose 0.53% to 6,118.71, while the Nasdaq Composite climbed 0.22% at 20,053.68 during Thursday's session.
Investors are awaiting earnings results from HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>), Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>, )) and American Express Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 47, the index moved to the &#8220;Neutral&#8221; zone on Thursday, versus a prior reading of 42.3.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43158901/jim-cramer-says-this-tech-stock-is-speculative-but-he-likes-it">Jim Cramer Says This Tech Stock Is Speculative But He Likes It</a></li>
</ul>
Photo courtesy: Shutterstock

S&P 500 Surges To Fresh Record Following Trump's Comments: Fear & Greed Index Moves To 'Neutral' Zone

HCA Healthcare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) will release earnings results for its fourth quarter, before the <a href="https://www.benzinga.com/quote/HCA/earnings">opening bell on Friday, Jan. 24, 2025.</a>
Analysts expect the Nashville, Tennessee-based company to report quarterly earnings at $6.14 per share, up from $5.9 per share in the year-ago period. HCA Healthcare projects to report revenue of $18.23 billion for the recent quarter, compared to $17.3 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Dec. 20, 2024, HCA Healthcare named Wendy Warren as Senior Vice President and Chief Ethics and Compliance Officer.
HCA Healthcare shares gained 1.8% to close at $325.36 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/hca/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Truist Securities analyst David Macdonald maintained a Buy rating and cut the price target from $430 to $390 on Jan. 6, 2025. This analyst has an accuracy rate of 65%.</li>
<li>Raymond James analyst John Ransom downgraded the stock from Outperform to Market Perform on Nov. 22, 2024. This analyst has an accuracy rate of 75%.</li>
<li>Keybanc analyst Matthew Gillmor maintained an Overweight rating and cut the price target from $475 to $420 on Oct. 28, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Oppenheimer analyst Michael Wiederhorn maintained an Outperform rating and raised the price target from $390 to $400 on Oct. 28, 2024. This analyst has an accuracy rate of 63%.</li>
<li>Deutsche Bank analyst Pito Chickering maintained a Buy rating and raised the price target from $359 to $375 on June 28, 2024. This analyst has an accuracy rate of 66%.</li>
</ul>
Considering buying HCA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="575" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/24024655/image-177-1024x575.png" alt="" class="wp-image-748199" style="width:574px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/24024655/image-177-1024x575.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/24024655/image-177-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/24024655/image-177-768x431.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/24024655/image-177.png 1117w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43158901/jim-cramer-says-this-tech-stock-is-speculative-but-he-likes-it">Jim Cramer Says This Tech Stock Is Speculative But He Likes It</a></li>
</ul>

HCA Healthcare Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

With U.S. stock futures trading slightly lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects American Express Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) to report quarterly earnings at $3.04 per share on revenue of $17.16 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. American Express shares gained 0.3% to $326.99 in after-hours trading.</li>
<li>Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) reported preliminary fourth-quarter financial results after the closing bell on Thursday. The company announced that it will recognize impacts to its quarterly results related to the IAM work stoppage and agreement, charges for certain Defense, Space &amp; Security programs, and costs associated with workforce reductions from last year. As a result, the airplane manufacturer now expects to report fourth-quarter revenue of $15.2 billion versus estimates of $16.27 billion, according to Benzinga Pro. Boeing also anticipates a fourth-quarter loss of $5.46 per share. Boeing shares fell 1.8% to $175.25 in the after-hours trading session.</li>
<li>Analysts expect Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) to post quarterly earnings at $1.10 per share on revenue of $35.32 billion. The company will release earnings before the markets open. Verizon shares gained 0.3% to $39.30 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) reported better-than-expected earnings and sales results for the fourth quarter after the market closed on Thursday. The company said it expects full-year 2025 worldwide da Vinci procedures to increase approximately 13% to 16%. Intuitive Surgical shares fell 2.2% to $595.00 in the after-hours trading session.</li>
<li>Analysts expect HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) to post quarterly earnings at $6.13 per share on revenue of $18.23 billion before the opening bell. HCA Healthcare shares gained 1.9% to $331.40 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43158901/jim-cramer-says-this-tech-stock-is-speculative-but-he-likes-it">Jim Cramer Says This Tech Stock Is Speculative But He Likes It</a></li>
</ul>
Photo courtesy: Shutterstock

Verizon, Boeing And 3 Stocks To Watch Heading Into Friday

Press Releases

HCA Healthcare Reports Third Quarter 2024 Results

HCA Healthcare Named a Best Employer for Veterans by Military Times for Fifth Consecutive Year

The Frist Foundation Gives $1 Million to the HCA Healthcare Hope Fund in Support of HCA Healthcare Colleagues Impacted by Hurricanes Helene and Milton

HCA Healthcare Collects Record-Breaking 21,137 Pounds of Medication During Sixth Annual "Crush the Crisis"

HCA Healthcare Names Wendy Warren as Senior Vice President and Chief Ethics and Compliance Officer

HCA Healthcare, Inc. 4th Quarter 2024 Earnings Conference Call

HCA Healthcare Reports Fourth Quarter 2024 Results and Provides 2025 Guidance

49 HCA Healthcare Hospitals Recognized as "America's Best Hospitals" by Healthgrades

HCA Announces Proposed Public Offering of Senior Notes

HCA Healthcare, Inc. to Present at March Healthcare Conferences

Acadia Healthcare Company, Inc. - Common Stock

Acadia Healthcare Co

Ardent Health Partners, Inc. Common Stock

Ardent Health Partners

Auna

IMAC Hldgs

Brookdale Senior Living Inc. Common Stock

Brookdale Senior Living

Concentra Group Holdings Parent, Inc. Common Stock

Concentra Group Holdings

Community Health Systems, Inc. Common Stock

Community Health Sys

Encompass Health Corporation Common Stock

Encompass Health

Ensign Group

Inspire Veterinary Partners, Inc. - Class A Common Stock

Inspire Veterinary

Joint

National HealthCare Corporation Common Stock

National Healthcare

PACS Group

Select Medical Holdings Corporation Common Stock

Select Medical Hldgs

Surgery Partners

Sonida Senior Living

SunLink Health Systems, Inc. Common Stock

SunLink Health Systems

Tenet Healthcare Corporation Common Stock

Tenet Healthcare

The Oncology Institute, Inc. - Common Stock

Oncology Institute

Universal Health Services, Inc. Common Stock

Universal Health Servs

US Physical Therapy

RBC Capital

B of A Securities

Cantor Fitzgerald

Barclays

Keybanc

화요일 오후, 워싱턴 D.C.의 한 연방 판사가 도널드 트럼프 대통령이 모든 연방 보조금과 대출을 동결한 행정 명령을 일시적으로 차단했다. 이 명령은 3조 달러의 자금을 위험에 빠뜨리고 <a href="https://www.benzinga.com/25/01/43290381/trumps-federal-spending-freeze-puts-3-trillion-in-limbo-threatens-industries-like-clean-energy-defense-healthcare">전체 산업을 불안</a>하게 만들었다.
상세 내용: 뉴욕 타임스의 <a href="https://www.nytimes.com/2025/01/28/us/politics/trump-funding-freeze-blocked.html" target="_blank" rel="noopener">보도</a>에 따르면 로렌 알리칸(Loren AliKhan) 판사는 민주주의 포워드가 제기한 소송에 대응하여 화요일 늦게 이 명령을 차단했다. 소송은 이 지시가 수정헌법 제1조와 행정절차법을 위반했다고 주장했다.
알리칸 판사는 2월 3일에 보다 영구적인 판결을 내릴 것이라고 밝혔다.
다음 읽기: <a href="https://www.benzinga.com/news/large-cap/25/01/43106379/trump-reverses-bidens-ai-policies-on-day-1-what-it-means-for-tech-giants-nvidia-amd-alphabet">트럼프, 첫날에 바이든의 AI 정책을 뒤집다: 기술 대기업인 엔비디아, AMD, 알파벳에 대한 의미</a>
스카이 페리먼(Skye Perryman), 민주주의 포워드의 사장 겸 CEO는 판사의 결정을 언급하며 성명에서 다음과 같이 말했다. &#8220;우리는 트럼프 행정부의 성급하고 잘못된 조치로 인한 혼란을 정리할 시간을 클라이언트들에게 주기 위한 이 행정적 정지를 감사히 생각한다&#8221;고 페리먼이 뉴욕 타임스에 말했다.
트럼프의 지시는 월요일에 관리예산국(OMB)에서 발행되었으며, 연방 기관들이 프로그램이 트럼프 행정부 정책에 맞는지 검토되는 동안 지출을 중단하도록 요구했으며, 화요일 오후 5시에 발효될 예정이었다.
그러나 화요일 아침, 주 메디케이드 프로그램이 연방 상환 포털이 잠겼다고 보고했다. 주 관계자들은 지역 보건 센터, 가족 식량 지원, 주택 지원, 유치원 및 재난 구호 자금이 불확실한 상태라고 말했다.
뉴욕 타임스에 따르면, 백악관과 OMB는 화요일 오후에 자금 동결이 &#8220;전면적으로 적용되지 않는다&#8221;고 말하며, D.E.I. 노력에 대한 프로그램과 &#8220;국익을 저해하는 조직&#8221;에 대한 자금 지원에 영향을 미쳤다고 밝혔다.
주목할 주식: 트럼프의 명령에 의해 어떤 산업이 영향을 받을지 또는 이 판사가 2월 3일에 이를 영구적으로 차단할지 명확하지 않다.
그러나 메디케이드 자금이 최소한 일시적으로 중단되었다고 보도되었다. HCA 헬스케어(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>)와 유니버설 헬스 서비스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>)의 주가가 화요일에 하락했다.
RTX(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>)와 록히드 마틴(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>)과 같은 대형 방산 계약자들도 정부 자금 및 계약에 대한 불확실성이 커지고 있다.
태양광 에너지를 포함한 녹색 산업도 트럼프 행정부의 정책으로 인해 연방 자금 지원에서 제외될 수 있다. 선노바 에너지 인터내셔널(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>)는 화요일에 12% 하락했고, 선런(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) 향후 정책 변화에 대한 불확실성으로 인해 9.2% 하락했습니다.
다음 읽기:
<ul>
<li><a href="https://www.benzinga.com/25/01/43287988/microsoft-q2-preview">마이크로소프트 2분기 실적 전망: 거리의 &#8216;너무 낙관적&#8217;인 단기 AI 수익?</a></li>
</ul>
사진: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

백악관이 모든 연방 보조금과 대출에 대한 일시적인 동결을 명령하면서 3조 달러의 자금이 재검토를 받게 되었고, 이는 의회의 재정 권력에 대한 법적 및 정치적 충돌의 무대를 설정하여 <a href="https://www.benzinga.com/markets" target="_blank" rel="noopener" data-google-interstitial="false">광범위한 산업</a>에 큰 영향을 미칠 수 있다.
이 지침은 월요일에 예산관리국(OMB)에 의해 발행되었고 여러 언론 매체에 의해 수신되었다. 모든 연방 기관은 프로그램이 도널드 트럼프 대통령의 정책 우선사항과 일치하는지 검토되는 동안 지급을 중단해야 한다.
여기에는 새로운 수여 중단, 기존 프로젝트에 대한 지급 및 자금 지원도 포함된다.
이 명령의 정확한 재정적 영향은 불확실하다. 예산 전문가들은 <a href="https://www.washingtonpost.com/business/2025/01/28/trump-spending-freeze-upends-washington-triggering-legal-threats-delays/">워싱턴 포스트</a>를 인용하여 적어도 수백억 달러가 걸려 있다고 언급했지만, 백악관 지침은 총액이 훨씬 더 높을 수 있음을 시사한다.
2024 회계연도에 연방 정부가 지출한 거의 10조 달러 중 3조 달러 이상이 연방 재정 지원이었다. 매튜 배스(Matthew Vaeth) OMB 대행 국장이 메모에서 밝혔다.
&#8220;재정 지원은 행정부의 우선사항을 발전시키는 데 전념해야 한다&#8221;고 배스가 말하며 &#8220;연방 자원을 마르크스주의적 평등, 성전환주의 및 그린 뉴딜 사회 공학 정책을 추진하는 데 사용하는 것은 납세자 자금의 낭비로서 우리가 봉사하는 사람들의 일상 생활을 개선하지 않는다&#8221;고 덧붙였다.
백악관은 사회 보장(사회보험)과 메디케어는 영향을 받지 않는다고 밝혔다. 이 광범위한 중단은 연방 지원에 의존하는 대학, 비영리 단체, 계약자 및 민간 회사들에 대한 자금 지원을 위협한다.
&#8220;이 메모의 어떤 내용도 메디케어나 사회 보장 혜택에 영향을 미친다고 해석되어서는 안 된다&#8221;라고 이 메모가 명시했다.
즉각적인 초점은 기관들이 면제를 처리하는 방법에 있을 것이다. OMB 메모는 연방 부서가 개별 승인을 요청할 수 있도록 허용하므로 일부 자금은 여전히 흐를 수 있지만, 과정은 느리게 진행되고 정치적으로 긴장이 고조될 가능성이 높다.
연방 기관들은 2025년 2월 10일까지 OMB에 어떤 프로그램, 프로젝트 및 활동이 자금 중단의 영향을 받는지를 자세히 보고해야 한다.
<h3 class="wp-block-heading">연방 자금을 둘러싼 법적, 정치적 충돌</h3>
이번 조치는 비영리 단체와 민주당 주들로부터 법적 도전을 촉발하고 있다.
발표 몇 시간 내에 뉴욕, 일리노이 및 오리건의 연방 법원에 소송이 제기되어 트럼프가 의회에서 승인된 지출을 유보할 권한이 없다고 주장했다.
척 슈머 상원 소수당 원내대표는 의회가 승인한 투자는 법적으로 의무화되어 있으며 대통령은 연방 자금에 대한 일방적인 행정 통제를 제한하는 1974년 압류 통제법을 무효화할 권한이 없다고 주장하면서 가장 먼저 반발했다.
트럼프는 1974년 법이 위헌이라고 오랫동안 주장해왔으며, 과거 대통령들은 이 법이 통과되기 전에는 지출에 대해 훨씬 더 많은 재량권을 가지고 있었다고 말했다.
<h3 class="wp-block-heading">어떤 산업들이 어려움에 직면할 수 있을까?</h3>
가장 큰 타격을 받을 수 있는 섹터는 클린 에너지, 국방, 건강 관리 및 교육 분야일 수 있다. 최근 몇 년 동안 연방 자금이 투자 및 성장을 주도하는 데 중요한 역할을 했다.
트럼프의 OMB 메모는 기후 이니셔티브와 청정 에너지 프로그램을 명시적으로 겨냥했다. 연방 자금 동결 이후 태양광 및 재생 가능 에너지 회사들의 주가가 가장 큰 타격을 받았다.
Invesco Solar ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAN#NYSE">TAN</a>)와 Invesco Wilderhill Clean Energy ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBW#NYSE">PBW</a>)는 각각 2%, 1.3% 하락했다.
선노바 에너지 인터내셔널(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>)는 12% 하락했고, 선런(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>)은 9.2% 하락했으며 솔라엣지 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>)는 5% 하락했다.
록히드 마틴(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), RTX(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) 및 노스롭 그루먼(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>)과 같은 방산 계약자들도 불확실성이 증가할 수 있다. 군사 지출이 전면적으로 삭감될 가능성은 낮지만, 여러 방산 계약자들은 연구 개발을 위한 연방 보조금에 의존하고 있다.
건강 관리에 미치는 영향은 불확실하다. 메디케어는 보호되지만, 병원, 관리 의료 제공자 및 제약 회사들을 지원하는 메디케이드 자금은 위험에 처할 수 있다.
HCA 헬스케어(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>)와 유니버설 헬스 서비스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>)는 각각 1% 및 1.4% 하락했으며, 테넷 헬스케어(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>)는 화요일에 회복세를 보였다.
다음 읽기:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43281252/fed-set-to-signal-no-rush-to-cut-rates-as-wall-street-awaits-policy-clarity">연준, 금리 인하 서두르지 않을 것 신호 예정 &#8211; 월스트리트가 정책 명확성 대기 중</a></li>
</ul>
사진 출처: Shutterstock.
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

CNN 머니 공포·탐욕 지수는 목요일(23일)에 &#8216;중립&#8217; 영역으로 이동하면서 전반적인 시장 심리가 더 개선된 것으로 나타났다.
목요일 미국 증시는 도널드 트럼프 대통령이 유가 인하를 촉구한 후 S&amp;P 500 지수가 장중 사상 최고치를 기록하는 등 상승세로 마감했다.
트럼프 대통령은 화상 회의를 통해 참석한 세계경제포럼에서 석유 및 가스 생산 확대를 옹호하고, 미국으로 제조업을 이전하는 기업에 대해 15%의 법인세율을 제안했다. 또한 미국과의 무역 적자가 큰 국가에 관세를 부과할 계획을 거듭 밝히며 유럽, 캐나다, 중국에 경고를 보냈다.
아메리칸항공 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>)은 예상보다 나은 2024년 4분기 실적을 발표했지만 약한 가이던스를 내놓았다. GE 에어로스페이스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>)는 예상보다 높은 4분기 실적을 발표했다.
경제지표 측면에서 1월 18일 종료되는 주간의 미국 신규 실업수당 청구건수는 전주 대비 6,000건 증가한 223,000건으로 시장 예상치인 220,000건에 비해 증가했다.
목요일에는 헬스케어, 부동산, 산업재 섹터가 상승세를 기록하면서 S&amp;P 500의 모든 업종이 상승으로 마감했다.
목요일 다우존스 지수는 약 408포인트 상승한 44,565.07포인트, S&amp;P 500 지수는 0.53% 상승한 6,118.71포인트로 마감했고, 나스닥 종합지수는 0.22% 상승한 20,053.68포인트로 마감했다.
투자자들은 오늘 HCA 헬스케어(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>), 버라이즌 커뮤니케이션스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>), 아메리칸 익스프레스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>)의 실적 발표를 기다리고 있다.
<h3>CNN 비즈니스 공포·탐욕 지수란?</h3>
공포·탐욕 지수는 현재 47로 목요일에 &#8216;중립&#8217; 영역으로 이동했으며, 이전 수치는 42.3였다.
공포·탐욕 지수는 현재 시장 심리를 측정하는 지표다. 공포가 높을수록 주가에 압력을 가하고, 탐욕이 높을수록 주가를 상승시킨다는 전제를 바탕으로 한다. 이 지수는 동일한 가중치를 가진 7가지 지표를 기준으로 계산된다. 지수의 범위는 0에서 100까지이며 0은 최대 공포를, 100은 최대 탐욕을 나타낸다.
사진 제공: Shutterstock
이 기사도 읽어보세요: <a href="https://kr.benzinga.com/news/usa/stocks/%EA%B8%88%EC%9A%94%EC%9D%BC-%EC%A3%BC%EB%AA%A9%ED%95%B4%EC%95%BC-%ED%95%A0-%EC%A3%BC%EC%8B%9D-%EC%95%84%EB%A9%94%EB%A6%AC%EC%B9%B8-%EC%9D%B5%EC%8A%A4%ED%94%84%EB%A0%88%EC%8A%A4-%EB%B3%B4%EC%9E%89/">금요일 주목해야 할 주식: 아메리칸 익스프레스, 보잉, 버라이즌, 인튜이티브 서지컬 및 HCA 헬스케어</a>
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

트럼프 발언 이후 S&P 500 사상 최고치 기록, 공포·탐욕 지수는 '중립' 영역으로 이동

금요일(24일) 아침 미국 주식 선물이 소폭 하락하는 가운데 오늘 투자자들의 관심을 끌 수 있는 주식들은 다음과 같다.
<ul>
<li>아메리칸 익스프레스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>): 오늘 개장 전 실적을 발표할 예정이며, 171억 6천만 달러의 매출과 3.04달러의 주당순이익이 예상된다. 주가는 시간외 거래에서 0.3 % 상승한 326.99달러를 기록했다.</li>
<li>보잉(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>): 목요일(23일) 장 마감 후 4분기 예비 실적을 발표했다. IAM 작업 중단 및 계약, 특정 국방, 우주 및 보안 프로그램에 대한 비용, 작년부터 인력 감축과 관련된 비용과 관련된 분기 실적에 영향을 미칠 것이라고 밝혔다. 결과적으로 보잉의 4분기 매출은 152억 달러로 예상치 162억 7,000만 달러에 비해 감소할 것으로 예상된다. 또한 4분기 주당 5.46달러의 손실이 예상되고 있다. 주가는 시간외 거래에서 1.8% 하락한 175.25달러를 기록했다.</li>
<li>버라이즌 커뮤니케이션스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>): 오늘 개장 전 실적을 발표할 예정이며 353억 2천만 달러의 매출에 주당 1.10달러의 분기 순익을 기록할 것으로 예상된다. 주가는 시간외 거래에서 0.3% 상승한 39.30달러를 기록했다.</li>
</ul>
자세한 내용은 <a href="https://www.benzinga.com/premarket/" target="_blank" rel="noopener">프리마켓 커버리지</a>를 확인하세요.
<ul>
<li>인튜이티브 서지컬(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>): 목요일 장 마감 후 4분기 예상보다 나은 수익과 판매 실적을 발표했다. 2025년 연간 전 세계 다빈치 로봇 시술 건수가 약 13%~16% 증가할 것으로 예상한다고 밝혔다. 시간외 거래 세션에서 주가는 2.2% 하락한 595.00달러를 기록했다.</li>
<li>HCA 헬스케어(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>): 오늘 개장 전 실적을 발표할 예정이며 182억 3천만 달러의 매출에 주당 6.13달러의 분기 순익을 기록할 것으로 예상된다. 주가는 시간외 거래에서 1.9% 상승한 331.40달러를 기록했다.</li>
</ul>
사진 출처: Shutterstock
이 기사도 읽어보세요: <a href="https://kr.benzinga.com/news/usa/economy/%ED%8A%B8%EB%9F%BC%ED%94%84-%EA%B4%80%EC%84%B8%EB%8A%94-%EC%96%B4%EB%96%BB%EA%B2%8C%EB%93%A0-%EC%A7%80%EB%8A%94-%EA%B2%8C%EC%9E%84-%EA%B3%A8%EB%93%9C%EB%A7%8C%EC%82%AD%EC%8A%A4-%EA%B4%80/" target="_blank" rel="noopener">트럼프 관세는 &#8216;어떻게든 지는 게임&#8217;? 골드만삭스 &#8220;관세 부과와 보복 관세로 시장 하락할 것&#8221;</a>
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

금요일 주목해야 할 주식: 아메리칸 익스프레스, 보잉, 버라이즌, 인튜이티브 서지컬 및 HCA 헬스케어

이들 10개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 아이콘(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLR#NASDAQ">ICLR</a>)의 주식은 <a href="https://www.benzinga.com//node/41500867" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">예상보다 저조한 실적</a>을 발표한 후 25.95% 급락했다. 여러 애널리스트들도 <a href="https://www.benzinga.com/quote/iclr/analyst-ratings" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">주가 목표</a>를 하향 조정했다.
2. 제뉴인 파츠(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>)의 주식은 엇갈린 3분기 실적과 <a href="https://www.benzinga.com//node/41455012" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">예상보다 낮은 2024년 EPS</a>를 발표한 후 20.21% 하락했다. 여러 애널리스트들이 <a href="https://www.benzinga.com/quote/gpc/analyst-ratings" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">주가 목표</a>를 하향 조정했다.
3. 뉴몬트(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>)의 주식은 <a href="https://www.benzinga.com//node/41503948" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">3분기 재무 실적</a>을 발표한 후 15.97% 하락했다. 애널리스트들은 <a href="https://www.benzinga.com/quote/nem/analyst-ratings" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">주가 목표</a>를 하향 조정했다.
4. 테넷 헬스케어(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>)의 주식은 지난주 14.71% 하락했다. 몇몇 헬스케어 주식과 병원 운영자들은 3분기 실적이 감소한 HCA 헬스케어에 동조세 가능성이 있었다.
5. 유니버셜 헬스 서비스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>)의 주식은 <a href="https://www.benzinga.com//node/41530333" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">3분기 재무 실적</a>을 발표한 후 지난주 14.33% 하락했다.
6. HCA 헬스케어(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>)의 주식은 <a href="https://www.benzinga.com//node/41544243" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">예상보다 저조한 3분기 재무 실적</a>을 발표한 후 12.51% 하락했다. 이 회사는 허리케인 헬렌의 영향이 2025년까지 지속될 것으로 예상하고 있다.
7. 탑빌드(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLD#NYSE">BLD</a>)의 주식은 허리케인 밀턴의 영향으로 주택 건설 주식이 <a href="https://www.benzinga.com//node/41317881" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">타격을 받은 후</a> 11.48% 하락했다.
8. 칼라일 컴퍼니(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSL#NYSE">CSL</a>)의 주식은 <a href="https://www.benzinga.com//node/41529849" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">예상보다 저조한 3분기 실적</a> 발표 후 11.45% 하락했다.
9. 테라다인(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>)의 주식은 <a href="https://www.benzinga.com//node/41503363" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">3분기 재무 실적</a>을 발표한 후 11.34% 하락했다. 일부 애널리스트들은 <a href="https://www.benzinga.com/quote/ter/analyst-ratings" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">주가 목표</a>를 하향 조정했다.
10. 컴포트 시스템즈 USA(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIX#NYSE">FIX</a>)의 주식은 <a href="https://www.benzinga.com//node/41530044" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">예상보다 저조한 3분기 매출 실적</a>을 발표한 후 11.27% 하락했다.
추가로 읽어보세요:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%ED%85%8C%EC%8A%AC%EB%9D%BC%EC%99%80-%EB%A6%AC-%EC%98%A4%ED%86%A0%EB%8A%94-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EA%B3%A0-%EC%84%B1%EA%B3%BC%EB%A5%BC-%EB%B3%B4%EC%97%AC%EC%A4%80-10%EA%B0%9C-%EB%8C%80/" target="_blank" rel="noopener">테슬라와 리 오토는 지난주 최고 성과를 보여준 10개 대형주 중 일부 (10월 21일-10월 25일)</a></li>
</ul>
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

ICLR

제뉴인 파츠 및 탑빌드가 지난주 최악의 성과를 보인 10개 대형주 중 일부 (10월 21일-10월 25일)

금요일 아침 (현지 시간 기준) 미국 주식 선물이 약간 높게 거래되면서 오늘 투자자의 관심을 끌 수 있는 일부 주식은 다음과 같다:
1. 월스트리트는 오토네이션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>)이 개장 전 분기별 주당 순이익 $4.38와 매출 $67.1억 달러를 보고할 것으로 예상하고 있다. 오토네이션의 주식은 애프터 마켓에서 0.4% 상승하여 $163.81에 거래되었다.
2. 캐피털 원 파이낸셜(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>)은 3분기 실적이 예상보다 좋게 나타났다. 이 회사는 분기별 주당 순이익 $4.51, 분기 매출 $100.14억 달러를 보고하였으며, 이는 각각 애널리스트 컨센서스 예상치인 $3.76 및 $98.61억 달러를 초과한 수치이다. 캐피털 원 파이낸셜의 주식은 애프터 마켓에서 4.9% 상승하여 $160.71에 거래되었다.
3. 애널리스트들은 콜게이트 팔모라이브(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>)가 분기별 주당 순이익 89센트와 매출 50억 달러를 보고할 것으로 예상하고 있다. 이 회사는 시장 개장 전에 실적을 발표할 예정이다. 콜게이트 팔모라이브의 주식은 애프터 마켓에서 0.7% 상승하여 $100.40에 거래되었다.
프리마켓 관련 보도를 <a href="https://www.benzinga.com/premarket/">여기에서 확인하세요</a>.
4. 에드워드 라이프사이언스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>)는 3분기 실적이 예상보다 좋았으나, 매출은 예상에 미치지 못했다. 애프터 마켓에서 에드워드 라이프사이언스의 주식은 4.4% 하락하여 $67.25에 거래되었다.
5. 애널리스트들은 HCA 헬스케어(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>)가 개장 전 분기별 주당 순이익 $4.96와 매출 $175.4억 달러를 보고할 것으로 예상하고 있다. HCA 헬스케어의 주식은 애프터 마켓에서 1% 하락하여 $395.00에 거래되었다.
사진 제공: AutoNation
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

HCA Healthcare

뉴스

에 대한 최신 뉴스 HCA Healthcare (NYSE:HCA) 주식

수요일, 1월 29, 2025

화요일, 1월 28, 2025

금요일, 1월 24, 2025

토요일, 10월 26, 2024

금요일, 10월 25, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌